Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Valleala

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1997
[Gingival tumor associated with joint pain]H Valleala, P Ranta
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 2, 2002
Clinical and biochemical response to single infusion of clodronate in active rheumatoid arthritis--a double blind placebo controlled studyH Valleala, K Laitinen, L Pylkkänen, et al.
Clinical and Experimental Rheumatology|January 21, 2012
Effect of oral clodronate on structural damage and bone turnover in rheumatoid arthritisH Valleala, L Laasonen, M-K Koivula, et al.
The Journal of Rheumatology|June 14, 2000
Inhibition of collagenase by a bisphosphonate-group drug in patients with rheumatoid arthritisH Valleala, O Teronen, C Friman, et al.
Duodecim; Laaketieteellinen Aikakauskirja|May 23, 2002
[The unknown SAPHO]H Valleala, M Montonen, C Lindqvist, et al.
Scandinavian Journal of Rheumatology|July 9, 2009
Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patientsH Valleala, M Korpela, T Möttönen, et al.
Life Sciences|September 5, 2003
Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonatesH Valleala, R Hanemaaijer, J Mandelin, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 11, 2002
[Tumor necrosis factor modulators in the treatment of rheumatoid arthritis]Y T Konttinen, H Valleala, V Honkanen, et al.
Scandinavian Journal of Rheumatology|July 19, 2012
Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trialM Hakala, H Kröger, H Valleala, et al.
Calcified Tissue International|July 1, 1997
Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate)O Teronen, Y T Konttinen, C Lindqvist, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1997
[Gingival tumor associated with joint pain]H Valleala, P Ranta
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 2, 2002
Clinical and biochemical response to single infusion of clodronate in active rheumatoid arthritis--a double blind placebo controlled studyH Valleala, K Laitinen, L Pylkkänen, et al.
Clinical and Experimental Rheumatology|January 21, 2012
Effect of oral clodronate on structural damage and bone turnover in rheumatoid arthritisH Valleala, L Laasonen, M-K Koivula, et al.
The Journal of Rheumatology|June 14, 2000
Inhibition of collagenase by a bisphosphonate-group drug in patients with rheumatoid arthritisH Valleala, O Teronen, C Friman, et al.
Duodecim; Laaketieteellinen Aikakauskirja|May 23, 2002
[The unknown SAPHO]H Valleala, M Montonen, C Lindqvist, et al.
Scandinavian Journal of Rheumatology|July 9, 2009
Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patientsH Valleala, M Korpela, T Möttönen, et al.
Life Sciences|September 5, 2003
Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonatesH Valleala, R Hanemaaijer, J Mandelin, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 11, 2002
[Tumor necrosis factor modulators in the treatment of rheumatoid arthritis]Y T Konttinen, H Valleala, V Honkanen, et al.
Scandinavian Journal of Rheumatology|July 19, 2012
Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trialM Hakala, H Kröger, H Valleala, et al.
Calcified Tissue International|July 1, 1997
Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate)O Teronen, Y T Konttinen, C Lindqvist, et al.
Pageof 2